Enhanc3D Genomics: Hazel Jones

Hazel Jones has been appointed as CEO of Enhanc3D Genomics, following her previous role as interim CEO and chief operating officer. Prior to joining the Cambridge, UK-based genome mapping company in 2023, she held various positions at AstraZeneca, including executive product director of clinical data and head of business planning and operations in oncology R&D. Before that, she was head of combination therapies at Cancer Research UK. Jones holds a BSc in pharmacology and a PhD in biochemistry from the University of Leeds.